Air pollution can adversely affect the immune response and increase the severity of the viral
disease. The present study aimed to explore the relationship between symptomatology, …

Long-term analyses of demographical and clinical characteristics of COVID-19 patients can
provide a better overview of the clinical course of the disease. They can also help …

Because the optimal treatment for COVID-19 is still unknown, it is important to explore every
potential way of improving the chances of survival for COVID-19 patients. The aim of the …

Background: Patients with kidney failure are at an increased risk of progression to a severe
form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was …

Background Remdesivir (RDV) is the only antiviral drug registered currently for treatment of
COVID-19 after a few clinical trials with controversial results. The purpose of this study was to …

Purpose The pathogenesis of coronavirus disease 2019 (COVID-19) is complicated, and in
addition to antiviral therapy and combating coagulopathy, treatment should also include …

Simple Summary Patients with active malignancies have an increased risk for severe SARS-CoV-2
infection and high mortality from COVID-19. Additionally, due to the underlying …

The COVID-19 vaccination has been the subject of unprecedented misinformation, false
news, and public concerns. This study presents a unique analysis comprising persons who …

Introduction and objective. Lyme borreliosis (LB) is a disease caused by the bacteria Borrelia
burgdorferi. The most common symptoms are related to the skin, musculo-scelatal system, …

Purpose The aim of the study was to assess the coagulation and inflammatory markers
connected with severe course of COVID-19 and no clinical improvement. Material and methods …